CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Operating expenses:
Research and development	$ 806,300	$ 445,400	$ 2,835,000	$ 1,476,600
General and administrative	1,335,500	671,300	6,514,500	2,024,600
Total operating expenses	2,141,800	1,116,700	9,349,500	3,501,200
Loss from operations	(2,141,800)	(1,116,700)	(9,349,500)	(3,501,200)
Other expenses, net:
Interest expense, net	$ (2,500)	(792,400)	(769,800)	(2,182,900)
Change in warrant liability		$ 953,700	(1,894,700)	528,300
Loss on extinguishment of debt			(26,700,200)	(2,371,400)
Other expense	$ (2,300)	$ (134,900)	(2,300)	(134,900)
Loss before income taxes	$ (2,146,600)	$ (1,090,300)	(38,716,500)	(7,662,100)
Income taxes			(2,300)	(2,400)
Net loss and comprehensive loss	$ (2,146,600)	$ (1,090,300)	(38,718,800)	$ (7,664,500)
Accrued dividends on Series B Preferred stock	(631,300)		(1,459,300)
Deemed dividend on Series B Preferred Units	(668,700)		(1,811,800)
Net loss attributable to common stockholders	$ (3,446,600)	$ (1,090,300)	$ (41,989,900)	$ (7,664,500)
Basic net loss attributable to common stockholders per common share	$ (1.95)	$ (0.84)	$ (25.45)	$ (6.03)
Diluted net loss attributable to common stockholders per common share	$ (1.95)	$ (1.08)	$ (25.45)	$ (6.14)
Weighted average shares used in computing basic net loss attributable to common stockholders per common share	1,765,641	1,302,300	1,650,160	1,270,495
Weighted average shares used in computing diluted net loss attributable to common stockholders per common share	1,765,641	1,302,300	1,650,160	1,288,674